Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Analytical Tool - Prostate Cancer: A Therapeutic' returned 271 results - Page 1 of 14   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Analytical Tool - Lung Cancer   Bioseeker, Feb 2012 Analytical Tool - Lung Cancer Analytical Tool - Lung Cancer is a premium combo product of "Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market" and "Lung Cancer Triple Analysis: Breast Cancer, Lung Cancer and Cancer Vaccines   Bioseeker, July 2011, Pages: 2895 : Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market Part III: Cancer Vaccines The cancer vaccine report part comprises defined and up to date development strategies Triple Analysis: Colorectal Cancer, Lung Cancer and Cancer Vaccines   Bioseeker, July 2011, Pages: 3038 cancer. This part is based on the following publication: A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market Part II: Lung Cancer The lung cancer Triple Analysis: Breast Cancer, Colorectal Cancer and Cancer Vaccines   Bioseeker, March 2011, Pages: 2628 publication: A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market Part III: Cancer Vaccines The cancer vaccine report part comprises defined and up to Triple Analysis: Breast Cancer, Colorectal Cancer and Lung Cancer   Bioseeker, July 2011, Pages: 3292 drug target strategies, and assesses them in eight different compound strategies in colorectal cancer. This part is based on the following publication: A Decision Support Tool for Optimizing The Triple Analysis: Lung Cancer, Pancreatic Cancer and Cancer Vaccines   Bioseeker, March 2012, Pages: 3085 cancer. This part is based on the following publication: Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market Part II: Pancreatic Cancer The pancreatic cancer report Triple Analysis: Breast Cancer, Pancreatic Cancer and Cancer Vaccines   Bioseeker, March 2012, Pages: 2675 strategies, and assesses them in 42 different cancer indications. This part is based on the following publication: Commercializing Cancer Vaccines: A Decision Support Tool for Optimizing the Pipeline The Triple Analysis: Breast Cancer, Lung Cancer and Pancreatic Cancer   Bioseeker, March 2012, Pages: 3339 strategies, and assesses them in eight different compound strategies and and three subindications of lung cancer. This part is based on the following publication: Lung Cancer: A Decision Support Tool for Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market   Bioseeker, July 2011, Pages: 1323 Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market This report comprises defined and up to date development strategies for 416 lung cancer drugs within the Triple Analysis: Colorectal Cancer, Pancreatic Cancer and Cancer Vaccines   Bioseeker, March 2012, Pages: 2818 colorectal cancer. This part is based on the following publication: A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market Part II: Pancreatic Cancer Triple Analysis: Colorectal Cancer, Lung Cancer and Pancreatic Cancer   Bioseeker, March 2012, Pages: 3482 on the following publication: A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market Part II: Lung Cancer The lung cancer report part comprises Triple Analysis: Breast Cancer, Colorectal Cancer and Pancreatic Cancer   Bioseeker, March 2012, Pages: 3072 , organized into 205 drug target strategies, and assesses them in eight different compound strategies in colorectal cancer. This part is based on the following publication: A Decision Support Tool for Triple Analysis: Lung Cancer, Cancer Vaccines and Antibodies   Bioseeker, Sep 2011, Pages: 3926 and three subindications of lung cancer. This part is based on the following publication: Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market Part II: Cancer Triple Analysis: Breast Cancer, Cancer Vaccines and Antibodies   Bioseeker, Sep 2011, Pages: 3516 publication: Commercializing Cancer Vaccines: A Decision Support Tool for Optimizing the Pipeline Part III: Antibodies The cancer antibody drug report part comprises defined and up to date development Triple Analysis: Lung Cancer, Apoptosis and Cancer Vaccines   Bioseeker, Dec 2011, Pages: 3599 cancer. This part is based on the following publication: Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market Part II: Apoptosis The apoptotic cancer drug report part Triple Analysis: Lung Cancer, Angiogenesis and Cancer Vaccines   Bioseeker, Jan 2012, Pages: 3686 cancer. This part is based on the following publication: Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market Part II: Angiogenesis The angiogenesis affecting cancer Triple Analysis: Lung Cancer, Cancer Vaccines and Peptides   Bioseeker, Nov 2011, Pages: 2888 and three subindications of lung cancer. This part is based on the following publication: Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market Part II: Cancer Triple Analysis: Breast Cancer, Apoptosis and Cancer Vaccines   Bioseeker, Dec 2011, Pages: 3189 different cancer indications. This part is based on the following publication: Commercializing Cancer Vaccines: A Decision Support Tool for Optimizing the Pipeline The report is written for you to Triple Analysis: Breast Cancer, Angiogenesis and Cancer Vaccines   Bioseeker, Jan 2012, Pages: 3276 strategies, and assesses them in 42 different cancer indications. This part is based on the following publication: Commercializing Cancer Vaccines: A Decision Support Tool for Optimizing the Pipeline The Triple Analysis: Breast Cancer, Cancer Vaccines and Peptides   Bioseeker, Nov 2011, Pages: 2478 : Commercializing Cancer Vaccines: A Decision Support Tool for Optimizing the Pipeline Part III: Peptides The cancer peptide drug report part comprises defined and up to date development strategies for 152 peptide Results:  First -   Prev -   1 -   2 -   3 -   4 -   5 -   6 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets2    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network